Mitsubishi Tanabe Pharma America
Gustavo Suarez has a strong work background in the pharmaceutical industry, with experience in various leadership roles in medical affairs. gustavo began their career at Bayer in 2008 as a Medical Director and then moved on to Acorda Therapeutics, Inc. in 2011, where they served as a Medical Director. In 2013, Gustavo joined Bayer HealthCare as a Global Medical Lead in neurology, but eventually left in 2016. gustavo then joined Ipsen as a Senior Medical Director in Medical Affairs, where they worked until 2019. Currently, they hold the position of VP US Medical Affairs at Mitsubishi Tanabe Pharma America, a position they have held since September 2019.
Gustavo Suarez pursued their education in the field of medicine and neurology. gustavo obtained a Doctorate in Medicine and Surgery from the Universidad Nacional de Colombia between 1990 and 1996. Following this, they specialized in Neurology by completing the Neurology Residency Program at Pontificia Universidad Javeriana from 1999 to 2003. Later, from 2006 to 2008, Gustavo undertook a Fellowship in Multiple Sclerosis at Baylor College of Medicine, focusing on this particular area of study. It is unclear whether they attended the Pedagogico institution, as there is no information about the start or end year, degree earned, or field of study.
Mitsubishi Tanabe Pharma America
We are taking on the challenges of complex and debilitating conditions and are committed to meeting the needs of people suffering from serious and often life-threatening illnesses. Today, we are focused on driving scientific discovery in many areas. Our focus remains on bringing treatment to people living with ALS as we strive to make a meaningful difference in their lives. Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs. We continue to expand our work to deepen our understanding of ALS, explore potential biomarkers to aid in further research and seek new answers. Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses. Please see our LinkedIn community guidelines here: http://www.mt-pharma-america.com/pdf/LinkedIn-Community-Guidelines.pdf